HRMY · Categories · Form 4

HRMY - SEC Form 4 insider transactions

Harmony Biosciences Holdings Inc. (HRMY) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for HRMY

• 15d
  SEC Form 4 filed by Director Germano Geno J

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 16d
  SEC Form 4 filed by Director Szyper Linda M

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 16d
  SEC Form 4 filed by Director Philip Ron M

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 16d
  SEC Form 4 filed by Director Graf R. Mark

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 16d
  SEC Form 4 filed by Director Sabater Juan A.

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 16d
  SEC Form 4 filed by Director Sender Gary

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 16d
  CHIEF MEDICAL OFFICER Budur Kumar converted options into 18,750 shares and covered exercise/tax liability with 8,882 shares, increasing direct ownership by 69% to 24,115 units (SEC Form 4) (for withholding tax)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 16d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Reicin Glenn

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 55d
  SEC Form 4 filed by Zaeske Adam H.

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 58d
  SEC Form 4 filed by Anastasiou Peter

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 58d
  SEC Form 4 filed by Ignelzi Troy A.

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 125d
  CHIEF FINANCIAL OFFICER Kapadia Sandip sold $139,171 worth of shares (3,746 units at $37.15), decreasing direct ownership by 13% to 24,521 units (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 128d
  CHIEF FINANCIAL OFFICER Kapadia Sandip converted options into 8,538 shares and covered exercise/tax liability with 4,792 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 128d
  CHIEF STRATEGY OFFICER Serafin Andrew converted options into 5,100 shares and covered exercise/tax liability with 2,242 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 128d
  CHIEF MEDICAL OFFICER Budur Kumar converted options into 4,850 shares and covered exercise/tax liability with 2,525 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 128d
  SEC Form 4 filed by CHIEF COMMERCIAL OFFICER Zaeske Adam H.

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 128d
  PRESIDENT, CEO Dayno Jeffrey M. converted options into 23,500 shares and covered exercise/tax liability with 10,439 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 133d
  CHIEF FINANCIAL OFFICER Kapadia Sandip sold $752,833 worth of shares (20,961 units at $35.92), closing all direct ownership in the company (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 168d
  PRESIDENT, CEO Dayno Jeffrey M. exercised 20,000 shares at a strike of $8.22 and sold $1,040,103 worth of shares (25,933 units at $40.11) (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 176d
  CHIEF FINANCIAL OFFICER Kapadia Sandip exercised 20,000 shares at a strike of $29.03 and sold $790,896 worth of shares (20,000 units at $39.54) (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 190d
  CHIEF FINANCIAL OFFICER Kapadia Sandip sold $119,945 worth of shares (3,427 units at $35.00), closing all direct ownership in the company (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 244d
  CHIEF FINANCIAL OFFICER Kapadia Sandip converted options into 45,000 shares and covered exercise/tax liability with 24,039 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 274d
  Large owner Valor Iv Pharma Holdings, Llc disposed of 6,618,033 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 288d
  CHIEF FINANCIAL OFFICER Kapadia Sandip sold $787,378 worth of shares (21,573 units at $36.50), closing all direct ownership in the company (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 383d
  SEC Form 4 filed by Director Sabater Juan A.

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 383d
  SEC Form 4 filed by Director Gracias Antonio J.

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 383d
  SEC Form 4 filed by Director Philip Ron M

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 383d
  SEC Form 4 filed by Director Szyper Linda M

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 383d
  SEC Form 4 filed by Director Anastasiou Peter

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 383d
  SEC Form 4 filed by Director Graf R. Mark

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 383d
  SEC Form 4 filed by Director Sender Gary

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 390d
  CHIEF MEDICAL OFFICER Budur Kumar converted options into 18,750 shares and covered exercise/tax liability with 8,869 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 413d
  SEC Form 4 filed by CHIEF COMMERCIAL OFFICER Zaeske Adam H.

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 425d
  SEC Form 4 filed by Director Philip Ron M

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 426d
  CHIEF FINANCIAL OFFICER Kapadia Sandip sold $227,386 worth of shares (6,987 units at $32.54), closing all direct ownership in the company (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 428d
  CHIEF FINANCIAL OFFICER Kapadia Sandip converted options into 15,000 shares and covered exercise/tax liability with 8,014 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 455d
  CHIEF COMMERCIAL OFFICER Dierks Jeffrey exercised 4,869 shares at a strike of $8.22 and sold $159,090 worth of shares (4,869 units at $32.67) (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 491d
  CHIEF MEDICAL OFFICER Budur Kumar converted options into 2,187 shares and covered exercise/tax liability with 1,151 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 491d
  CHIEF COMMERCIAL OFFICER Dierks Jeffrey exercised 15,812 shares at a strike of $25.47, sold $551,575 worth of shares (14,754 units at $37.38) and covered exercise/tax liability with 1,058 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 491d
  PRESIDENT, CEO Dayno Jeffrey M. converted options into 10,500 shares and covered exercise/tax liability with 4,567 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 491d
  CHIEF FINANCIAL OFFICER Kapadia Sandip sold $67,547 worth of shares (1,775 units at $38.05), converted options into 3,812 shares and covered exercise/tax liability with 2,037 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 491d
  CHIEF STRATEGY OFFICER Serafin Andrew converted options into 2,500 shares and covered exercise/tax liability with 865 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 496d
  PRESIDENT, CEO Dayno Jeffrey M. sold $774,245 worth of shares (19,293 units at $40.13) and exercised 19,293 shares at a strike of $8.22 (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 496d
  CHIEF FINANCIAL OFFICER Kapadia Sandip exercised 25,000 shares at a strike of $29.03 and sold $1,004,598 worth of shares (25,000 units at $40.18) (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 497d
  CHIEF COMMERCIAL OFFICER Dierks Jeffrey exercised 30,598 shares at a strike of $33.44 and sold $1,147,715 worth of shares (30,598 units at $37.51) (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 503d
  CHIEF COMMERCIAL OFFICER Dierks Jeffrey exercised 10,507 shares at a strike of $33.44 and sold $388,841 worth of shares (10,507 units at $37.01) (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 504d
  CHIEF COMMERCIAL OFFICER Dierks Jeffrey exercised 7,180 shares at a strike of $33.44 and sold $265,946 worth of shares (7,180 units at $37.04) (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 574d
  Large owner Valor Iv Pharma Holdings, Llc sold $139,391,500 worth of shares (4,600,000 units at $30.30), decreasing direct ownership by 41% to 6,618,033 units (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 575d
  Large owner Marshman Fund Trust Ii sold $139,391,500 worth of shares (4,600,000 units at $30.30), decreasing direct ownership by 43% to 6,051,120 units (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 580d
  CHIEF COMMERCIAL OFFICER Dierks Jeffrey sold $870,018 worth of shares (21,496 units at $40.47) and exercised 21,496 shares at a strike of $24.00 (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 609d
  CHIEF COMMERCIAL OFFICER Dierks Jeffrey sold $16,077 worth of shares (400 units at $40.19) and exercised 400 shares at a strike of $24.00 (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 609d
  CHIEF COMMERCIAL OFFICER Dierks Jeffrey covered exercise/tax liability with 23,643 shares and converted options into 60,000 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 609d
  CHIEF FINANCIAL OFFICER Kapadia Sandip converted options into 60,000 shares and covered exercise/tax liability with 32,052 shares (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 610d
  CHIEF COMMERCIAL OFFICER Dierks Jeffrey exercised 35,846 shares at a strike of $24.00 and sold $1,434,951 worth of shares (35,846 units at $40.03) (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 611d
  CHIEF COMMERCIAL OFFICER Dierks Jeffrey sold $8,009 worth of shares (200 units at $40.05) and exercised 200 shares at a strike of $24.00 (SEC Form 4)

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 733d
  SEC Form 4 filed by Sender Gary

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 733d
  SEC Form 4 filed by Gracias Antonio J.

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 733d
  SEC Form 4 filed by Sabater Juan A.

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 733d
  SEC Form 4 filed by Graf R. Mark

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)
• 733d
  SEC Form 4 filed by Nielsen Jack

  4 - Harmony Biosciences Holdings, Inc. (0001802665) (Issuer)

Other HRMY categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends